VAPO vs. PYPD, INBS, PSTV, NURO, TMDIF, GCTK, OSA, VVOS, AFIB, and UTRS
Should you be buying Vapotherm stock or one of its competitors? The main competitors of Vapotherm include PolyPid (PYPD), Intelligent Bio Solutions (INBS), Plus Therapeutics (PSTV), NeuroMetrix (NURO), Titan Medical (TMDIF), GlucoTrack (GCTK), ProSomnus (OSA), Vivos Therapeutics (VVOS), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "surgical & medical instruments" industry.
Vapotherm (NYSE:VAPO) and PolyPid (NASDAQ:PYPD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability.
Vapotherm has a beta of -1.15, meaning that its share price is 215% less volatile than the S&P 500. Comparatively, PolyPid has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500.
Vapotherm received 67 more outperform votes than PolyPid when rated by MarketBeat users. However, 72.41% of users gave PolyPid an outperform vote while only 53.99% of users gave Vapotherm an outperform vote.
PolyPid has a net margin of 0.00% compared to Vapotherm's net margin of -84.74%. Vapotherm's return on equity of 0.00% beat PolyPid's return on equity.
PolyPid has lower revenue, but higher earnings than Vapotherm. PolyPid is trading at a lower price-to-earnings ratio than Vapotherm, indicating that it is currently the more affordable of the two stocks.
In the previous week, Vapotherm and Vapotherm both had 1 articles in the media. PolyPid's average media sentiment score of 1.89 beat Vapotherm's score of 0.34 indicating that PolyPid is being referred to more favorably in the news media.
43.1% of Vapotherm shares are held by institutional investors. Comparatively, 26.5% of PolyPid shares are held by institutional investors. 15.8% of Vapotherm shares are held by company insiders. Comparatively, 24.7% of PolyPid shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Vapotherm and PolyPid tied by winning 7 of the 14 factors compared between the two stocks.
Get Vapotherm News Delivered to You Automatically
Sign up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VAPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Vapotherm Competitors List
Related Companies and Tools